MeCure Industries
Fundamental Profile & Historical Analysis · NGX-Listed Equity
₦56.20
0.00 (0.00%)
Close on 23 Oct 2026 · End of day, Nigerian Exchange
Previous close
₦56.20
Day range
₦56.20 – 56.20
52-week range
₦27.70 – 104.00
Volume
3,924
Value traded
₦199,073
₦56.20Fri, 23 Oct 2026Volume 4k
Closing prices as published by the Nigerian Exchange, not adjusted for dividends, share splits or consolidations. Daily for the last year, weekly before that.
Returns
| Period | Price | With dividends | Market | Sector |
|---|---|---|---|---|
| 1D | 0.0% | 0.0% | +0.9% | -0.4% |
| 1W | 0.0% | 0.0% | -0.1% | -0.5% |
| 1M | 0.0% | 0.0% | -1.5% | +0.4% |
| 3M | -9.9% | -9.9% | -0.1% | -12.6% |
| 6M | -6.3% | -5.8% | +10.5% | -9.4% |
| YTD | -13.8% | -13.4% | +59.7% | +21.3% |
| 1Y | +83.1% | +84.0% | +61.6% | +90.4% |
| 3Y | — | — | +272.7% | +654.9% |
| 5Y | — | — | +492.1% | +1124.7% |
Price returns use closes adjusted for splits and consolidations. “With dividends” adds back cash dividends. Market and sector are TickerNG's own market-cap-weighted price indices built from NGX closes and share counts; they are not NGX's All-Share Index.
Risk and liquidity
Worst fall, 5 years
-46.0%
Below its high now
-46.0%
Volatility, 1 year
57.5%
Beta vs market
0.01
Avg daily volume, 3 months
305,121
Days traded, last 63
63
The worst fall ran from Jan 2026 to Jul 2026 and has not regained its peak.
From split-adjusted closes, without dividends. Beta is against TickerNG's own market index (not NGX's), from weekly moves over 154 weeks.
Dividend history
Paid in 3 years in a row · paid in 3 of the last 10 years
| Year | Per share | Payments |
|---|---|---|
| 2026 | ₦0.32unconfirmed | final |
| 2025 | ₦0.15 | dividend |
| 2024 | ₦0.15 | dividend |
Cash dividends in naira, by the year of the ex-dividend date, from NGX corporate notices. Not a forecast.
Versus healthcare peers
MECURE among 7 listed companies in the sector, annual figures for FY2025
| Measure | MECURE | Peer median | Rank | Ahead of |
|---|---|---|---|---|
| Market cap | ₦225bn | ₦24bn | 2 of 7 | — |
| P/Elower is cheaper | 34.7× | 33.1× | 3 of 4 | — |
| P/Blower is cheaper | 11.3× | 10.9× | 3 of 4 | — |
| ROEhigher is better | 32.6% | 24.4% | 2 of 4 | — |
| ROAhigher is better | 7.9% | 7.0% | 1 of 4 | — |
| Net marginhigher is better | 8.3% | 6.9% | 2 of 4 | — |
| Dividend yieldhigher is better | 0.6% | — | 1 of 1 | — |
Only companies with the figure are counted. With fewer than five, no percentile is shown. A cheaper P/E is not by itself a better company.
Valuation, with your assumptions
Change any assumption and the values follow. Defaults: the required return is the latest 364-day T-bill stop rate plus 5 points; growth is MECURE's own dividend growth where it has a record.
Dividend discount
₦0.95
-98% vs price
Starts from ₦0.15 a share (2025 payments).
Discounted earnings
₦6.60
-88% vs price
From earnings of ₦1.62 a share.
Peer multiples (healthcare)
₦51.84 to ₦869.24
-4% vs price
P/E at the peers' quartiles; at the median P/B: ₦54.20. Peers are not identical businesses.
Discounted earnings: value per share as the required return (across) and growth (down) change
| Growth \ Return | 23.0% | 24.0% | 25.0% | 26.0% | 27.0% |
|---|---|---|---|---|---|
| 6.0% | ₦6.85 | ₦6.49 | ₦6.16 | ₦5.87 | ₦5.60 |
| 7.0% | ₦7.10 | ₦6.72 | ₦6.38 | ₦6.07 | ₦5.79 |
| 8.0% | ₦7.36 | ₦6.96 | ₦6.60 | ₦6.28 | ₦5.99 |
| 9.0% | ₦7.62 | ₦7.20 | ₦6.83 | ₦6.50 | ₦6.19 |
| 10.0% | ₦7.89 | ₦7.46 | ₦7.07 | ₦6.72 | ₦6.40 |
These are tools for testing a view, not forecasts or advice. A result is only as sound as the assumptions: the dividend model needs a steady payer, and earnings are not cash. A blank value means the inputs cannot give one (for example a required return at or below growth).
Key Metrics — FY2025 Source: annual report ↗
Revenue
₦77.7bn
Profit After Tax
₦6.5bn
Total Assets
₦82.0bn
Total Equity
₦19.8bn
EPS (Basic)
₦1.62
Net Margin
8.3%
Return on Equity
32.6%
TickerNG provides research and information only. Nothing here is a recommendation to buy, sell or hold any security, and TickerNG is not a licensed investment adviser or broker. Figures are taken from company filings and market data and may be incomplete, delayed or restated, so check them against the linked source. Reports are generated with AI from that data and can contain errors. Past performance does not predict future results, and you can lose money. Make your own decision, or speak to a licensed adviser. Terms
Run a live verification on MECURE
Multi-specialist AI analysis — fundamentals, news, macro, sentiment, and a contrarian challenge — synthesised into a sourced investment thesis.
Verify MECURE on TickerNG →Free tier available. No credit card required.